Strata Critical Medical (SRTA) Interest & Investment Income (2019 - 2026)

Strata Critical Medical has disclosed Interest & Investment Income across 7 years of filings, most recently posting $473000.0 for Q1 2026.

• In Q1 2026, Interest & Investment Income fell 64.19% year-over-year to $473000.0; the TTM figure through Mar 2026 stood at $3.4 million (down 47.5% YoY), while the FY2025 annual figure was $4.2 million, down 41.21% from the prior year.
• Interest & Investment Income fell to $473000.0 in Q1 2026, from $638000.0 in the prior quarter.
• Over the last five years, Interest & Investment Income for SRTA reached as high as $2.3 million in Q4 2023 and fell as low as $473000.0 in Q1 2026.
• The 4-year median for Interest & Investment Income is $1.7 million (2024), against an average of $1.5 million.
• Annual changes were most pronounced in 2024 — Interest & Investment Income declined 13.91% — and 2026, when it tumbled 64.19%.
• A 4-year view of Interest & Investment Income shows it stood at $2.3 million in 2023, then dropped by 29.77% to $1.6 million in 2024, then plunged by 59.87% to $638000.0 in 2025, then declined by 25.86% to $473000.0 in 2026.
• According to Business Quant data, Interest & Investment Income over the past three periods registered $473000.0, $638000.0, and $1.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.